X-RAY crystallography (XRC) structure studies & surface plasmon resonance (SPR) studies
Ended Purchase Order Awarded Last action
- Contract number
- 75N95022P00669
- Awardee
-
Schrodinger, Inc. UEI NSUESF38DS83
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $247,500
Award facts
- Opportunity
-
- X-ray crystallography (XRC) Structure Studies & Surface Plasmon Resonance (SPR) Studies COVID-19 Special Notice · 75N95022Q00465 · Posted Jul 26, 2022
- Contract value 100% obligated
- $247,500.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10036, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $247,500 |
About this award
The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, awarded a $247,500 firm-fixed-price purchase order to Schrodinger, Inc. for X-ray crystallography (XRC) structure studies and surface plasmon resonance (SPR) studies. This requirement supports the agency's efforts to optimize compounds against bacterial enzymes. Schrodinger, Inc. is a for-profit organization that has previously received prime federal contracts and grants, including a $540,000 purchase order from the Drug Enforcement Administration for scientific software licenses. This award does not have a set-aside designation.
Quick answers
Who was awarded contract 75N95022P00669?
75N95022P00669 was awarded to Schrodinger, Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 23, 2022.
How much is contract 75N95022P00669 worth?
The government has obligated $247,500 on 75N95022P00669.
Which agency awarded contract 75N95022P00669?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022P00669, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95022P00669 competed?
The extent of competition for 75N95022P00669 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award